According to research reviewed by Gram, a 2026 study in mice found that tiny particles from the probiotic Lactobacillus rhamnosus GG may help repair fatty liver disease. Growing the bacteria at 28°C roughly doubled particle production, and the particles appeared to reduce liver fat and calm gut and liver inflammation. These results are early and have not been tested in people.
Fatty liver disease, now called MASLD, affects many adults and is closely tied to problems in the gut and liver. A 2026 study in the Journal of Extracellular Vesicles tested tiny particles released by Lactobacillus rhamnosus GG, a well-known probiotic bacterium. The researchers found that growing the bacteria at a cooler temperature of 28°C roughly doubled how many of these particles they produced. In mice fed a high-fat diet, the particles collected in the liver, where they appeared to help balance bile acids, reduce fat buildup, and calm inflammation. They also seemed to strengthen the gut lining and shift gut bacteria toward a healthier mix. According to research reviewed by Gram, these results are promising, but they come from animal experiments and do not yet show whether the approach works in people.
Key Statistics
A 2026 study published in the Journal of Extracellular Vesicles found that growing Lactobacillus rhamnosus GG at 28°C roughly doubled the number of extracellular vesicles it released.
In a 2026 mouse study of fatty liver disease, Lactobacillus rhamnosus GG-derived vesicles preferentially collected in the liver and were linked to less liver fat and reduced inflammation.
A 2026 study in high-fat diet mice reported increases in beneficial gut bacteria such as Akkermansia and Muribaculaceae after treatment with probiotic-derived vesicles.
The Quick Take
- What they studied: Can tiny particles released by a common probiotic bacterium, produced under a cooler growing temperature, help repair the liver and gut in mice with fatty liver disease?
- Who participated: The study used laboratory mice fed a high-fat diet to make them develop fatty liver disease. The exact number of mice was not stated in the summary provided.
- Key finding: Growing the probiotic at 28°C roughly doubled the amount of particles it released. In the mice, these particles collected in the liver and were linked to less liver fat, less inflammation, healthier gut bacteria, and a stronger gut lining.
- What it means for you: This is early laboratory research in animals. It does not mean that eating probiotics or taking a supplement will fix fatty liver disease. Anyone with liver concerns should talk with a doctor about proven steps like weight management, healthy eating, and regular exercise.
The Research Details
The researchers first grew Lactobacillus rhamnosus GG, a probiotic bacterium found in some yogurts and supplements, at a cooler temperature of 28°C. This cold stress caused the bacteria to release more tiny sacs called extracellular vesicles, which carry chemical messages. The team then collected and purified these particles and checked that they still worked well.
Next, the researchers gave the particles by injection into the belly of mice that had been fed a high-fat diet for a long time, a standard way to create fatty liver disease in animals. They then tracked where the particles traveled in the body and measured changes in the liver, intestines, and gut bacteria. The experiments looked at many biological markers, including genes that control fat production, bile acid levels, and proteins that seal the gut wall.
Because this was an animal study, it could test cause and effect in a controlled way. Researchers could compare treated mice with untreated mice that ate the same diet. This kind of design is useful for exploring how a treatment might work, but it cannot tell us how the same treatment would affect people.
Animal studies like this are an important first step. They let scientists look inside the liver and gut in ways that are not possible in people, and they can reveal the biological pathways a treatment might use. Comparing treated and untreated mice on the same diet helps show whether the particles themselves made the difference.
The study was published in the Journal of Extracellular Vesicles, a peer-reviewed scientific journal focused on this research area. The abstract describes several connected experiments that point in the same direction, which adds some confidence. However, the summary does not state the number of mice used, so it is harder to judge how strong the statistical evidence is. Results from mice are also not guaranteed to apply to humans, and the diet used to cause fatty liver in mice differs from how the disease develops in people.
What the Results Show
The most notable result was the production step. Growing the probiotic at 28°C about doubled the number of vesicles it released, and the researchers reported that these particles kept their biological activity. This matters because producing enough material is a major challenge for any future treatment built from bacterial particles.
After injection, the particles gathered mainly in the liver of the mice. There, they appeared to correct bile acid balance, which are digestive fluids made by the liver that also act as chemical signals. The researchers linked this effect to changes in genes that control how the liver makes and breaks down bile acids. Once bile acid levels in the liver improved, less bile acid seemed to build up in the intestines.
In the liver, the treatment also reduced fat buildup by quieting genes that drive fat production, and it appeared to calm inflammation by blocking signaling pathways that promote it. In the intestines, the treatment increased proteins that tighten the connections between gut cells, which may reduce leaks of harmful substances into the body. The gut microbiome also shifted toward a mix that included beneficial bacteria such as Akkermansia and Muribaculaceae, and the ratio of Firmicutes to Bacteroidota bacteria moved in a direction linked to better metabolic health.
The researchers described the treatment as safe in their mouse experiments, which is an important early finding for any future medicine. The findings suggest that the liver and gut influence each other in both directions, so treating one may help the other. This two-way link is one reason the researchers believe the approach could target fatty liver disease at more than one point.
Previous research has connected fatty liver disease with imbalances in gut bacteria, bile acid problems, and a weakened gut barrier. This study builds on that work by suggesting a single approach may address all three. Earlier studies on probiotics have shown mixed results in people, so using bacterial particles instead of live bacteria is a newer direction that still needs much more testing.
The study was done in mice, and mice are not people. The mice received the particles by injection into the belly, which is not how most people would take a treatment, so a practical product would need a different delivery method. The summary also does not state how many mice were studied or how long the treatment lasted, which makes the strength of the findings harder to judge. Finally, the research has not yet been tested in human clinical trials, so safety and effectiveness in people remain unknown.
The Bottom Line
At this stage, there is no recommendation for people to use these particles or to change their care based on this study. Confidence is low for human use because the evidence comes only from animal experiments. Confidence is moderate that the research is worth following, since the results were consistent across several measurements. Proven steps for fatty liver disease, such as losing weight if needed, eating a balanced diet, staying active, and limiting alcohol, still have far stronger evidence.
People with fatty liver disease, doctors, and researchers who study liver health and gut bacteria may find this work worth following. People who are looking for a quick fix or a new supplement should not rely on this study, since the treatment has only been tested in mice. Anyone with liver disease should discuss treatment options with their healthcare provider rather than trying new products on their own.
Turning laboratory findings like these into a human treatment usually takes many years. A typical path includes further animal testing, safety studies in people, and several phases of clinical trials. Most people should not expect any new treatment from this research for a long time, if it ever becomes available.
Frequently Asked Questions
Can probiotic particles help treat fatty liver disease?
Early research in mice suggests particles from Lactobacillus rhamnosus GG may reduce liver fat and inflammation. These findings come only from animal studies, so they have not been proven to help people with fatty liver disease.
What is MASLD and how is it related to the gut?
MASLD, or metabolic dysfunction-associated steatotic liver disease, is a condition where fat builds up in the liver. Research suggests problems in the gut, including imbalanced bacteria and weakened gut lining, may contribute to the disease.
Do probiotics cure fatty liver disease?
No single probiotic has been shown to cure fatty liver disease in people. Weight management, a balanced diet, regular exercise, and limiting alcohol remain the best-supported steps, and a doctor should guide any treatment plan.
How does cold shock change probiotic bacteria?
Growing Lactobacillus rhamnosus GG at a cooler 28°C caused it to release about twice as many extracellular vesicles, according to the study. These tiny particles carry biological signals and may be easier to produce in larger amounts than whole bacteria.
Want to Apply This Research?
- Track your weekly habits that support liver health, such as the number of days you eat vegetables, the number of days you exercise for at least 30 minutes, and your alcohol intake. If you have a doctor’s guidance on weight, log your weight once a week under the same conditions.
- Use the app to set one realistic goal, such as adding a vegetable to lunch or walking for 20 minutes after dinner three days a week. Review your progress each week and build from there. Share any changes with your doctor, especially before starting any supplement.
- Over several months, review trends in weight, activity, diet, and any lab results your doctor shares with you. Look for steady patterns rather than day-to-day changes. Bring these logs to medical appointments so your care team can see the full picture and adjust the plan as needed.
This article summarizes an early laboratory study conducted in mice and has not been tested in humans. It is for general education only and is not medical advice. Do not start, stop, or change any supplement or treatment for liver disease without first talking to a qualified healthcare provider.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.